AI Articles and Analysis in Chemicals

This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

According to research from the American Society for Biochemistry and Molecular Biology, nine out of 10 drugs fail to make it to market in the clinical trials process. Researchers in the cited studies found that 40-50% of these failures are due to a lack of clinical efficacy, meaning that the drug is not able to produce its intended effect in people, and 30% were due to unmanageable toxicity or side effects.

This interview analysis is sponsored by Arkestro and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Quantiphi and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

AI and data science have seen increased use in life sciences, particularly in the pharmaceutical industry. However, despite the multitude of AI use cases, pharmaceutical companies tend not to embrace every emerging AI trend eagerly. 

Companies that use AI copilots experience numerous benefits, including streamlined processes, improved customer experience, and cost savings. Large language models (LLMs) form the basis of many AI copilot applications. While LLMs have a remarkable capacity to generate humanlike text, that same capability is the reason businesses need to exercise caution in order to prevent misapplications of this otherwise transformative technology.